NEW YORK, July 17, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Sarepta Therapeutics, Inc. (NASDAQ: SRPT) between June 22, 2023 and June 24, 2025, both dates inclusive (the “Class Period”), of the important August 25, 2025 lead plaintiff deadline.

In a market landscape marked by fluctuating commodity prices and geopolitical uncertainties, Alcoa Corporation‘s AA recent financial performance offers a glimpse into the evolving dynamics of the aluminum industry.

Electric vehicle (EV) stock Lucid Group Inc (NASDAQ:LCID) is surging today, up 38.8% to trade at $3.18 at last check, after the company announced Uber Technologies (UBER) will invest $300 million in a robotaxi deal.

NEW YORK, July 17, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Reddit, Inc. (NYSE: RDDT) between October 29, 2024 and May 20, 2025, both dates inclusive (the “Class Period”), of the important August 18, 2025 lead plaintiff deadline.

NEW YORK, July 17, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Cleveland-Cliffs Inc. (NYSE: CLF) resulting from allegations that Cliffs may have issued materially misleading business information to the investing public.

Uber is a dominant, profitable, asset-light platform benefiting from secular trends in mobility and delivery, with strong global brand and network effects. Autonomous vehicles (AVs) are a key catalyst, poised to enhance Uber's margins, reduce regulatory risks, and expand its addressable market. Autonomous vehicles (AVs) have the potential to reduce labor classification disputes inherent in the gig-economy model.

Amazon's greenhouse gas emissions rose by 6% last year, due mostly to pollution generated by the company's delivery fleet and increased data center construction.

Wipro Limited (NYSE:WIT ) Q1 2026 Earnings Conference Call July 17, 2025 9:30 AM ET Company Participants Aparna C. Iyer - Senior VP, CFO & Member of Executive Board Dipak Kumar Bohra - Corporate Participant SVP & Chief of Internal Audit - Corporate Participant Srinivas Pallia - CEO, MD, Executive Director & Member of Executive Board Conference Call Participants Kumar Rakesh - BNP Paribas Exane, Research Division Gaurav Rateria - Morgan Stanley, Research Division Ashwin Mehta - AMBIT Capital Private Limited, Research Division Abhishek Kumar - JM Financial Institutional Securities Limited, Research Division Manik Taneja - Axis Capital Limited, Research …

Ernest Hoffman is a Crypto and Market Reporter for Kitco News. He has over 15 years of experience as a writer, editor, broadcaster and producer for media, educational and cultural organizations.

NEW YORK, July 17, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Biohaven Ltd. (NYSE: BHVN) between March 24, 2023 and May 14, 2025, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than September 12, 2025.

SAN FRANCISCO, July 17, 2025 (GLOBE NEWSWIRE) -- On June 25, 2025, securities class action lawsuits were filed against Hims & Hers Health, Inc. (NYSE: HIMS) and certain of the company's executives. The cases seeks to represent investors who purchased or otherwise acquired Hims & Hers securities between April 29, 2025 and June 23, 2025.

The U.S. Dollar Index remains in a clear bearish trend for 2025, with lower lows and resistance levels capping any rallies. Multiple factors weigh on the dollar: high U.S. debt, political division, tariffs, and global moves away from the dollar as a reserve currency. Despite some potential catalysts for a rebound, the risk-reward profile currently favors a short position in the dollar index.

Main Street Capital stock trades at a premium to NAV, but this is justified by consistent NAV growth, tax efficiency, and unique equity investments. Including special dividends, MAIN's yield is higher than it appears, and NAV growth pushes total return to around 10.5% annually. MAIN's internally managed structure and equity investments enable NAV accretion and lower expenses, differentiating it from peers like ARCC.

NEW YORK , July 17, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Organon & Co. (NYSE: OGN) between November 3, 2022 and April 30, 2025, both dates inclusive (the "Class Period"), of the important July 22, 2025 lead plaintiff deadline. So what: If you purchased Organon securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

SAN FRANCISCO, July 17, 2025 (GLOBE NEWSWIRE) -- Healthcare giant Centene Corporation (NYSE: CNC), a prominent provider of government-sponsored and commercial healthcare services, finds itself embroiled in a class action lawsuit following a dramatic plunge in its stock price. The suit, Lunstrum v. Centene Corporation, No. 25-cv-05659 (S.D.N.Y.), seeks to represent investors who purchased or acquired Centene securities between December 12, 2024, and June 30, 2025, alleging violations of the Securities Exchange Act of 1934.

SAN FRANCISCO, July 17, 2025 (GLOBE NEWSWIRE) -- When, on May 27, 2025, Rocket Pharmaceuticals (NASDAQ: RCKT) revealed that the FDA put a clinical hold on its Phase 2 pivotal trial for RP-A501, an experimental therapy intended to treat patients with a rare gene disorder called Danon disease, investors in the company's shares saw their investment crash over 60% that day.

NEW YORK , July 17, 2025 /PRNewswire/ -- Omnicom (NYSE: OMC) and Interpublic (NYSE: IPG) today announced the Australia Competition and Consumer Commission (ACCC) has granted clearance for Omnicom's pending acquisition of Interpublic. The ACCC approval brings the total number of antitrust approvals to 14 out of the 18 required for closing.

The Travelers Companies, Inc. (NYSE:TRV ) Q2 2025 Earnings Conference Call July 17, 2025 9:30 AM ET Company Participants Abbe F. Goldstein - Senior Vice President of Investor Relations Alan David Schnitzer - Chairman & CEO Daniel Stephen Frey - Executive VP & CFO Gregory Cheshire Toczydlowski - Executive VP & President of Business Insurance Jeffrey Peter Klenk - Executive VP and President of Bond & Specialty Insurance Michael Frederick Klein - Executive VP & President of Personal Insurance Conference Call Participants Brian Robert Meredith - UBS Investment Bank, Research Division Cave Mohaghegh Montazeri - Deutsche Bank AG, Research Division …

Lucas Downey expects a seasonal pullback after the steep SPX rally. He urges investors not to panic and instead buy on the anticipated dip.

Sean McNulty, The Ankler contributor, joins 'Power Lunch' to discuss Netflix's quarterly earnings results.